# __Cortical Labs Launches World's First Biological Computer: The CL1__, (from page [20250309](https://kghosh.substack.com/p/20250309).)

__[External link](https://newatlas.com/brain/cortical-bioengineered-intelligence/)__



## Keywords

* Cortical Labs
* CL1
* Synthetic Biological Intelligence
* SBI
* neural networks
* biocomputer
* AI

## Themes

* biological computer
* AI technology
* neural networks
* biotechnology

## Other

* Category: science
* Type: news

## Summary

Cortical Labs has launched the world's first biological computer, the CL1, which integrates human brain cells with silicon technology to form synthetic biological intelligence (SBI). Unveiled on March 2, 2025, in Barcelona, the CL1 aims to revolutionize AI by offering a more dynamic, energy-efficient, and sustainable alternative to traditional silicon-based systems. This innovative device, which employs organic neural networks, is geared towards advancing research in medicine and technology, including drug discovery and robotics. The CL1 can be purchased or accessed via cloud-based 'Wetware-as-a-Service' (WaaS), making it accessible to a wider range of researchers. While it introduces groundbreaking technology, the full extent of its potential is yet to be realized as users begin to explore its capabilities.

## Signals

| name                                     | description                                                                                | change                                                                                               | 10-year                                                                                                      | driving-force                                                                                     |   relevancy |
|:-----------------------------------------|:-------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------------------|:-------------------------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------|------------:|
| Biological Computer Launch               | First commercial launch of a biological computer combining human brain cells with silicon. | Transition from conventional silicon-based computing to biologically integrated computing.           | Widespread adoption of biological computers in diverse fields including AI, robotics, and medicine.          | Advancements in biotechnology and the need for energy-efficient computing solutions.              |           5 |
| Wetware-as-a-Service (WaaS)              | Commercial model allowing remote access to biological computing resources via the cloud.   | Shift from localized, high-cost research to democratized access to advanced computational resources. | Increased innovation in research and development across various fields through accessible computing power.   | Desire for collaboration and equal access to cutting-edge technologies in research.               |           4 |
| Minimal Viable Brain Concept             | Research aimed at creating a simplified, functional brain model using biological neurons.  | From complex traditional models to streamlined biological systems for intelligence research.         | Possibility of establishing more controllable and profound insights into neural functions and intelligence.  | Necessity to deepen understanding of brain functionality and its applications in AI and medicine. |           4 |
| Ethical AI and Biotechnology Discussions | Emerging debates around ethics concerning biological computing and consciousness.          | Rising importance of ethical considerations in technology development and usage.                     | Stricter regulations and frameworks governing the use of biological technologies and their societal impacts. | Increased public awareness and advocacy for responsible technology usage.                         |           5 |
| Bioengineering for Drug Discovery        | Utilization of biological computers to enhance drug discovery and disease modeling.        | From traditional drug testing methods to innovative, biologically driven approaches.                 | Potential reduction in animal testing and improved drug development timelines and success rates.             | Need for more effective and ethical approaches in biomedical research and drug development.       |           5 |
| Demo of Neural Network Adaptation        | Demonstration of lab-grown neurons adapting and learning through stimulation.              | Advancement from static models to dynamic, adaptable biological networks.                            | Potential to innovate machine learning and AI systems with more organic learning processes.                  | Search for more advanced, efficient ways to replicate intelligence in machines.                   |           4 |

## Concerns

| name                                         | description                                                                                                                     |   relevancy |
|:---------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------|------------:|
| Ethical Concerns in Biological Computing     | The use of human neurons raises ethical questions about consciousness and sentience, requiring stringent regulations.           |           4 |
| Unpredictable Consequences of SBI Technology | The rapid advancement of synthetic biological intelligence may lead to unforeseen negative applications and consequences.       |           5 |
| Regulatory and Compliance Risks              | Navigating complex regulatory landscapes may hinder the responsible deployment of SBI technologies.                             |           4 |
| Funding Challenges for Hybrid Technologies   | The unique nature of SBI complicates its funding, risking delays in research and technology development.                        |           3 |
| Risks of Overreliance on Biological Models   | Reliance on biological computing for drug discovery may neglect the nuances of human biology and lead to inadequate treatments. |           4 |
| Potential Market Disruption                  | The affordable access to SBI technology might disrupt existing medical and research markets, causing economic instability.      |           3 |
| Impact on Animal Testing Practices           | The potential to replace animal testing raises ethical questions regarding the validity and reliability of SBI tests.           |           4 |
| Long-term Viability of Wetware Systems       | The sustainability and maintenance of biocomputers are uncertain, posing risks to the field of biological computing.            |           3 |

## Behaviors

| name                             | description                                                                                                                          |   relevancy |
|:---------------------------------|:-------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Biological Computing             | The integration of human brain cells with silicon hardware to create dynamic, evolving neural networks for advanced computing.       |           5 |
| Wetware-as-a-Service (WaaS)      | Accessing biological computing power remotely through cloud systems, democratizing advanced research capabilities.                   |           5 |
| Sustainable AI Development       | A focus on creating AI systems that are energy efficient and sustainable, using biological materials instead of silicon.             |           4 |
| Personalized Drug Discovery      | Using biological computers to revolutionize drug discovery and tailored treatments based on complex neural adaptations.              |           4 |
| Ethical Biotechnology Regulation | Establishment of regulations for the responsible use of biological computing, addressing concerns of consciousness and sentience.    |           4 |
| Collaborative Research Platforms | Providing a platform for researchers worldwide to engage with cutting-edge technology in real-time for collaborative breakthroughs.  |           4 |
| Minimal Viable Brain Concept     | Investigating the least complex neural architecture necessary to exhibit cognitive functions, driving understanding of intelligence. |           3 |
| Transdisciplinary Technology     | Blending various fields such as biotechnology, AI, and medicine to foster innovative solutions beyond traditional categories.        |           4 |

## Technologies

| name                                    | description                                                                                                                              |   relevancy |
|:----------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Synthetic Biological Intelligence (SBI) | A biological computer integrating human brain cells with silicon to form dynamic neural networks for advanced AI capabilities.           |           5 |
| Wetware-as-a-Service (WaaS)             | A service model allowing researchers to access biological computing technology and neural networks via the cloud.                        |           4 |
| Biological Neural Networks              | A platform employing lab-grown neurons on electrodes to create systems mimicking brain functions for research and computation.           |           5 |
| Minimal Viable Brain (MVB)              | A concept aimed at bioengineering a simplified brain model for studying intelligence and neurological processes.                         |           4 |
| Induced Pluripotent Stem Cells (iPSCs)  | Stem cells capable of developing into various cell types, used to build neural networks for research in brain functionality.             |           5 |
| Biological Computing Technology         | Technologies that leverage biological substrates, such as neurons, to perform computations in ways that differ from traditional methods. |           5 |

## Issues

| name                                                  | description                                                                                                                               |   relevancy |
|:------------------------------------------------------|:------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Synthetic Biological Intelligence (SBI)               | A new computing intelligence merging human brain cells with silicon, expected to revolutionize technology and research applications.      |           5 |
| Ethical considerations in biological computing        | The emergence of bioengineered neural networks raises questions about consciousness and sentience in biological computing.                |           5 |
| Wetware-as-a-Service (WaaS)                           | A new model of accessing biological computing resources remotely through the cloud, democratizing access for researchers.                 |           4 |
| Replacement of animal testing                         | The CL1 system aims to reduce dependencies on animal testing in medical research, raising ethical and practical implications.             |           4 |
| Minimal Viable Brain concept                          | A pursuit to bioengineer a simplified brain model that could allow for dynamic information processing and intelligence studies.           |           4 |
| Funding challenges for interdisciplinary technologies | Cortical Labs faces difficulties in securing funding due to its cross-disciplinary nature between technology and medicine.                |           3 |
| Potential for drug discovery and disease modeling     | SBI could significantly advance research in drug development for neurological diseases, addressing high failure rates in clinical trials. |           5 |
| Regulatory compliance in biological technologies      | The need for regulatory oversight in the use and commercialization of biological computing technologies to ensure ethical practices.      |           4 |